-
1
-
-
79952232216
-
Global cancer statistics
-
10.3322/caac.20107
-
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D, (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90. doi:10.3322/caac.20107. PubMed: 21296855.
-
(2011)
CA Cancer J Clin
, vol.61
, pp. 69-90
-
-
Jemal, A.1
Bray, F.2
Center, M.M.3
Ferlay, J.4
Ward, E.5
Forman, D.6
-
2
-
-
33846457870
-
Cancer statistics, 2007
-
10.3322/canjclin.57.1.43
-
Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ, (2007) Cancer statistics, 2007. CA Cancer J Clin 57: 43-66. doi:10.3322/canjclin.57.1.43. PubMed: 17237035.
-
(2007)
CA Cancer J Clin
, vol.57
, pp. 43-66
-
-
Jemal, A.1
Siegel, R.2
Ward, E.3
Murray, T.4
Xu, J.5
Thun, M.J.6
-
3
-
-
78650236850
-
Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC
-
10.1016/S0169-5002(11)70140-4
-
Chang A, (2011) Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC. Lung Cancer 71: 3-10. doi:10.1016/S0169-5002(11)70140-4. PubMed: 20951465.
-
(2011)
Lung Cancer
, vol.71
, pp. 3-10
-
-
Chang, A.1
-
4
-
-
84869500199
-
Epigenomics and interindividual differences in drug response
-
10.1038/clpt.2012.152
-
Ivanov M, Kacevska M, Ingelman-Sundberg M, (2012) Epigenomics and interindividual differences in drug response. Clin Pharmacol Ther 92: 727-736. doi:10.1038/clpt.2012.152. PubMed: 23093317.
-
(2012)
Clin Pharmacol Ther
, vol.92
, pp. 727-736
-
-
Ivanov, M.1
Kacevska, M.2
Ingelman-Sundberg, M.3
-
5
-
-
84930481235
-
Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes
-
10.1124/pr.111.005637
-
Shen DW, Pouliot LM, Hall MD, Gottesman MM, (2012) Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes. Pharmacol Rev 64: 706-721. doi:10.1124/pr.111.005637. PubMed: 22659329.
-
(2012)
Pharmacol Rev
, vol.64
, pp. 706-721
-
-
Shen, D.W.1
Pouliot, L.M.2
Hall, M.D.3
Gottesman, M.M.4
-
6
-
-
84865471981
-
miRNAs as mediators of drug resistance
-
10.2217/epi.12.39
-
Haenisch S, Cascorbi I, (2012) miRNAs as mediators of drug resistance. Epigenomics 4: 369-381. doi:10.2217/epi.12.39. PubMed: 22920178.
-
(2012)
Epigenomics
, vol.4
, pp. 369-381
-
-
Haenisch, S.1
Cascorbi, I.2
-
7
-
-
78149403591
-
MacroRNA underdogs in a microRNA world: evolutionary, regulatory, and biomedical significance of mammalian long non-protein-coding RNA
-
10.1016/j.bbagrm.2010.10.001
-
Lipovich L, Johnson R, Lin CY, (2010) MacroRNA underdogs in a microRNA world: evolutionary, regulatory, and biomedical significance of mammalian long non-protein-coding RNA. Biochim Biophys Acta 1799: 597-615. doi:10.1016/j.bbagrm.2010.10.001. PubMed: 20951849.
-
(2010)
Biochim Biophys Acta
, vol.1799
, pp. 597-615
-
-
Lipovich, L.1
Johnson, R.2
Lin, C.Y.3
-
8
-
-
84864395101
-
Long non-coding RNAs and human disease
-
10.1042/BST20120020
-
Harries LW, (2012) Long non-coding RNAs and human disease. Biochem Soc Trans 40: 902-906. doi:10.1042/BST20120020. PubMed: 22817756.
-
(2012)
Biochem Soc Trans
, vol.40
, pp. 902-906
-
-
Harries, L.W.1
-
9
-
-
77954818666
-
MicroRNA and drug resistance
-
20467450
-
Ma J, Dong C, Ji C, (2010) MicroRNA and drug resistance. Cancer Gene Ther 17: 523-531. PubMed: 20467450.
-
(2010)
Cancer Gene Ther
, vol.17
, pp. 523-531
-
-
Ma, J.1
Dong, C.2
Ji, C.3
-
10
-
-
34250782196
-
HOTAIR lifts noncoding RNAs to new levels
-
10.1016/j.cell.2007.06.014
-
Woo CJ, Kingston RE, (2007) HOTAIR lifts noncoding RNAs to new levels. Cell 129: 1257-1259. doi:10.1016/j.cell.2007.06.014. PubMed: 17604716.
-
(2007)
Cell
, vol.129
, pp. 1257-1259
-
-
Woo, C.J.1
Kingston, R.E.2
-
11
-
-
84878767058
-
Association of large noncoding RNA HOTAIR expression and its downstream intergenic CpG island methylation with survival in breast cancer
-
10.1007/s10549-012-2314-z
-
Lu L, Zhu G, Zhang C, Deng Q, Katsaros D, et al. (2012) Association of large noncoding RNA HOTAIR expression and its downstream intergenic CpG island methylation with survival in breast cancer. Breast Cancer Res Treat 136: 875-883. doi:10.1007/s10549-012-2314-z. PubMed: 23124417.
-
(2012)
Breast Cancer Res Treat
, vol.136
, pp. 875-883
-
-
Lu, L.1
Zhu, G.2
Zhang, C.3
Deng, Q.4
Katsaros, D.5
-
12
-
-
84872797539
-
Clinical significance of the expression of long non-coding RNA HOTAIR in primary hepatocellular carcinoma
-
23292722
-
Ishibashi M, Kogo R, Shibata K, Sawada G, Takahashi Y, et al. (2013) Clinical significance of the expression of long non-coding RNA HOTAIR in primary hepatocellular carcinoma. Oncol Rep 29: 946-950. PubMed: 23292722.
-
(2013)
Oncol Rep
, vol.29
, pp. 946-950
-
-
Ishibashi, M.1
Kogo, R.2
Shibata, K.3
Sawada, G.4
Takahashi, Y.5
-
13
-
-
84875890253
-
HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer
-
10.1038/onc.2012.193
-
Kim K, Jutooru I, Chadalapaka G, Johnson G, Frank J, et al. (2013) HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. Oncogene 32: 1616-1625. doi:10.1038/onc.2012.193. PubMed: 22614017.
-
(2013)
Oncogene
, vol.32
, pp. 1616-1625
-
-
Kim, K.1
Jutooru, I.2
Chadalapaka, G.3
Johnson, G.4
Frank, J.5
-
14
-
-
80054029971
-
Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers
-
21862635
-
Kogo R, Shimamura T, Mimori K, Kawahara K, Imoto S, et al. (2011) Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res 71: 6320-6326. PubMed: 21862635.
-
(2011)
Cancer Res
, vol.71
, pp. 6320-6326
-
-
Kogo, R.1
Shimamura, T.2
Mimori, K.3
Kawahara, K.4
Imoto, S.5
-
15
-
-
84877609777
-
Induction of long intergenic non-coding RNA HOTAIR in lung cancer cells by type I collagen
-
10.1186/1756-8722-6-35
-
Zhuang Y, Wang X, Nguyen HT, Zhuo Y, Cui X, et al. (2013) Induction of long intergenic non-coding RNA HOTAIR in lung cancer cells by type I collagen. Hematol Oncol 6: 35. doi:10.1186/1756-8722-6-35.
-
(2013)
Hematol Oncol
, vol.6
, pp. 35
-
-
Zhuang, Y.1
Wang, X.2
Nguyen, H.T.3
Zhuo, Y.4
Cui, X.5
-
16
-
-
78649807567
-
Phosphorylation of the PRC2 component Ezh2 is cell cycle-regulated and up-regulates its binding to ncRNA
-
10.1101/gad.1983810
-
Kaneko S, Li G, Son J, Xu CF, Margueron R, et al. (2010) Phosphorylation of the PRC2 component Ezh2 is cell cycle-regulated and up-regulates its binding to ncRNA. Genes Dev 24: 2615-2620. doi:10.1101/gad.1983810. PubMed: 21123648.
-
(2010)
Genes Dev
, vol.24
, pp. 2615-2620
-
-
Kaneko, S.1
Li, G.2
Son, J.3
Xu, C.F.4
Margueron, R.5
-
17
-
-
84866455756
-
Enhancer of zeste homolog 2 is overexpressed and contributes to epigenetic inactivation of p21 and phosphatase and tensin homolog in B-cell acute lymphoblastic leukemia
-
10.1258/ebm.2012.012075
-
Chen J, Li J, Han Q, Sun Z, Wang J, et al. (2012) Enhancer of zeste homolog 2 is overexpressed and contributes to epigenetic inactivation of p21 and phosphatase and tensin homolog in B-cell acute lymphoblastic leukemia. Exp Biol Med (Maywood) 237: 1110-1116. doi:10.1258/ebm.2012.012075.
-
(2012)
Exp Biol Med (Maywood)
, vol.237
, pp. 1110-1116
-
-
Chen, J.1
Li, J.2
Han, Q.3
Sun, Z.4
Wang, J.5
-
18
-
-
84875590101
-
Long noncoding RNAs: past, present, and future
-
10.1534/genetics.112.146704
-
Kung JT, Colognori D, Lee JT, (2013) Long noncoding RNAs: past, present, and future. Genetics 193: 651-669. doi:10.1534/genetics.112.146704. PubMed: 23463798.
-
(2013)
Genetics
, vol.193
, pp. 651-669
-
-
Kung, J.T.1
Colognori, D.2
Lee, J.T.3
-
19
-
-
77954855829
-
Non-coding RNAs: Meet thy masters
-
10.1002/bies.200900112
-
Costa FF, (2010) Non-coding RNAs: Meet thy masters. Bioessays 32: 599-608. doi:10.1002/bies.200900112. PubMed: 20544733.
-
(2010)
Bioessays
, vol.32
, pp. 599-608
-
-
Costa, F.F.1
-
20
-
-
0035966319
-
microRNAs: tiny regulators with great potential
-
10.1016/S0092-8674(01)00616-X
-
Ambros V, (2001) microRNAs: tiny regulators with great potential. Cell 107: 823-826. doi:10.1016/S0092-8674(01)00616-X. PubMed: 11779458.
-
(2001)
Cell
, vol.107
, pp. 823-826
-
-
Ambros, V.1
-
21
-
-
80053045739
-
Molecular mechanisms of long noncoding RNAs
-
10.1016/j.molcel.2011.08.018
-
Wang KC, Chang HY, (2011) Molecular mechanisms of long noncoding RNAs. Mol Cell 43: 904-914. doi:10.1016/j.molcel.2011.08.018. PubMed: 21925379.
-
(2011)
Mol Cell
, vol.43
, pp. 904-914
-
-
Wang, K.C.1
Chang, H.Y.2
-
22
-
-
61849133411
-
Long intronic noncoding RNA transcription: expression noise or expression choice?
-
10.1016/j.ygeno.2008.11.009
-
Louro R, Smirnova AS, Verjovski-Almeida S, (2009) Long intronic noncoding RNA transcription: expression noise or expression choice? Genomics 93: 291-298. doi:10.1016/j.ygeno.2008.11.009. PubMed: 19071207.
-
(2009)
Genomics
, vol.93
, pp. 291-298
-
-
Louro, R.1
Smirnova, A.S.2
Verjovski-Almeida, S.3
-
23
-
-
79953858658
-
No-nonsense functions for long noncoding RNAs
-
10.1016/j.cell.2011.03.014
-
Nagano T, Fraser P, (2011) No-nonsense functions for long noncoding RNAs. Cell 145: 178-181. doi:10.1016/j.cell.2011.03.014. PubMed: 21496640.
-
(2011)
Cell
, vol.145
, pp. 178-181
-
-
Nagano, T.1
Fraser, P.2
-
24
-
-
79957840356
-
Long noncoding RNAs and human disease
-
10.1016/j.tcb.2011.04.001
-
Wapinski O, Chang HY, (2011) Long noncoding RNAs and human disease. Trends Cell Biol 21: 354-361. doi:10.1016/j.tcb.2011.04.001. PubMed: 21550244.
-
(2011)
Trends Cell Biol
, vol.21
, pp. 354-361
-
-
Wapinski, O.1
Chang, H.Y.2
-
25
-
-
67650921949
-
Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression
-
10.1073/pnas.0904715106
-
Khalil AM, Guttman M, Huarte M, Garber M, Raj A, et al. (2009) Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci U S A 106: 11667-11672. doi:10.1073/pnas.0904715106. PubMed: 19571010.
-
(2009)
Proc Natl Acad Sci U S A
, vol.106
, pp. 11667-11672
-
-
Khalil, A.M.1
Guttman, M.2
Huarte, M.3
Garber, M.4
Raj, A.5
-
26
-
-
78651390167
-
Long intergenic noncoding RNAs: new links in cancer progression
-
10.1158/1538-7445.AM2011-3
-
Tsai MC, Spitale RC, Chang HY, (2011) Long intergenic noncoding RNAs: new links in cancer progression. Cancer Res 71: 3-7. doi:10.1158/1538-7445.AM2011-3. PubMed: 21199792.
-
(2011)
Cancer Res
, vol.71
, pp. 3-7
-
-
Tsai, M.C.1
Spitale, R.C.2
Chang, H.Y.3
-
27
-
-
84877147615
-
Long noncoding RNA: an emerging paradigm of cancer research
-
10.1007/s13277-013-0658-6
-
Qiu MT, Hu JW, Yin R, Xu L, (2013) Long noncoding RNA: an emerging paradigm of cancer research. Tumour Biol 34: 613-620. doi:10.1007/s13277-013-0658-6. PubMed: 23359273.
-
(2013)
Tumour Biol
, vol.34
, pp. 613-620
-
-
Qiu, M.T.1
Hu, J.W.2
Yin, R.3
Xu, L.4
-
28
-
-
34250782196
-
HOTAIR lifts noncoding RNAs to new levels
-
10.1016/j.cell.2007.06.014
-
Woo CJ, Kingston RE, (2007) HOTAIR lifts noncoding RNAs to new levels. Cell 129: 1257-1259. doi:10.1016/j.cell.2007.06.014. PubMed: 17604716.
-
(2007)
Cell
, vol.129
, pp. 1257-1259
-
-
Woo, C.J.1
Kingston, R.E.2
-
29
-
-
77956404036
-
HOTAIR: Flight of noncoding RNAs in cancer metastasis
-
10.4161/cc.9.17.13122
-
Wan Y, Chang HY, (2010) HOTAIR: Flight of noncoding RNAs in cancer metastasis. Cell Cycle 9: 3391-3392. doi:10.4161/cc.9.17.13122. PubMed: 20864820.
-
(2010)
Cell Cycle
, vol.9
, pp. 3391-3392
-
-
Wan, Y.1
Chang, H.Y.2
-
30
-
-
77951118936
-
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
-
10.1038/nature08975
-
Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, et al. (2010) Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464: 1071-1076. doi:10.1038/nature08975. PubMed: 20393566.
-
(2010)
Nature
, vol.464
, pp. 1071-1076
-
-
Gupta, R.A.1
Shah, N.2
Wang, K.C.3
Kim, J.4
Horlings, H.M.5
-
31
-
-
84863393119
-
Upregulation of miR-196a and HOTAIR drive malignant character in gastrointestinal stromal tumors
-
10.1158/1538-7445.AM2012-1126
-
Niinuma T, Suzuki H, Nojima M, Nosho K, Yamamoto H, et al. (2012) Upregulation of miR-196a and HOTAIR drive malignant character in gastrointestinal stromal tumors. Cancer Res 72: 1126-1136. doi:10.1158/1538-7445.AM2012-1126. PubMed: 22258453.
-
(2012)
Cancer Res
, vol.72
, pp. 1126-1136
-
-
Niinuma, T.1
Suzuki, H.2
Nojima, M.3
Nosho, K.4
Yamamoto, H.5
-
32
-
-
78650236850
-
Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC
-
10.1016/S0169-5002(11)70140-4
-
Chang A, (2011) Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC. Lung Cancer 71: 3-10. doi:10.1016/S0169-5002(11)70140-4. PubMed: 20951465.
-
(2011)
Lung Cancer
, vol.71
, pp. 3-10
-
-
Chang, A.1
-
33
-
-
33847347345
-
Epigenetic markers and response to chemotherapy in cancer
-
10.1155/2007/610815
-
Strathdee G, (2007) Epigenetic markers and response to chemotherapy in cancer. Dis Markers 23: 43-49. doi:10.1155/2007/610815. PubMed: 17325425.
-
(2007)
Dis Markers
, vol.23
, pp. 43-49
-
-
Strathdee, G.1
-
34
-
-
84856466661
-
The role of EZH2 in tumour progression
-
10.1038/bjc.2011.551
-
Chang CJ, Hung MC, (2012) The role of EZH2 in tumour progression. Br J Cancer 106: 243-247. doi:10.1038/bjc.2011.551. PubMed: 22187039.
-
(2012)
Br J Cancer
, vol.106
, pp. 243-247
-
-
Chang, C.J.1
Hung, M.C.2
-
35
-
-
84865161055
-
Myeloid malignancies: mutations, models and management
-
22823977
-
Murati A, Brecqueville M, Devillier R, Mozziconacci MJ, Gelsi-Boyer V, et al. (2012) Myeloid malignancies: mutations, models and management. BMC Cancer 12: 304. PubMed: 22823977.
-
(2012)
BMC Cancer
, vol.12
, pp. 304
-
-
Murati, A.1
Brecqueville, M.2
Devillier, R.3
Mozziconacci, M.J.4
Gelsi-Boyer, V.5
-
36
-
-
84871748742
-
EZH2 promotes malignant behaviors via cell cycle dysregulation and its mRNA level associates with prognosis of patient with non-small cell lung cancer
-
10.1371/journal.pone.0052984
-
Cao W, Ribeiro Rde O, Liu D, Saintigny P, Xia R, et al. (2012) EZH2 promotes malignant behaviors via cell cycle dysregulation and its mRNA level associates with prognosis of patient with non-small cell lung cancer. PLOS ONE 7: e52984. doi:10.1371/journal.pone.0052984. PubMed: 23300840.
-
(2012)
PLOS ONE
, vol.7
-
-
Cao, W.1
Ribeiro Rde, O.2
Liu, D.3
Saintigny, P.4
Xia, R.5
-
38
-
-
67649424560
-
p21 in cancer: intricate networks and multiple activities
-
10.1038/nrc2657
-
Abbas T, Dutta A, (2009) p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer 9: 400-414. doi:10.1038/nrc2657. PubMed: 19440234.
-
(2009)
Nat Rev Cancer
, vol.9
, pp. 400-414
-
-
Abbas, T.1
Dutta, A.2
-
39
-
-
0028884881
-
Prognostic significance of p53 and ras p21 expression in nonsmall cell lung cancer
-
10.1002/1097-0142(19951215)76:12
-
Fujino M, Dosaka-Akita H, Harada M, Hiroumi H, Kinoshita I, et al. (1995) Prognostic significance of p53 and ras p21 expression in nonsmall cell lung cancer. Cancer 76: 2457-2463. doi:10.1002/1097-0142(19951215)76:12. PubMed: 8625071.
-
(1995)
Cancer
, vol.76
, pp. 2457-2463
-
-
Fujino, M.1
Dosaka-Akita, H.2
Harada, M.3
Hiroumi, H.4
Kinoshita, I.5
-
40
-
-
0032065130
-
Inhibition of tumor cell growth by p21WAF1 adenoviral gene transfer in lung cancer
-
9622102
-
Joshi US, Chen YQ, Kalemkerian GP, Adil MR, Kraut M, et al. (1998) Inhibition of tumor cell growth by p21WAF1 adenoviral gene transfer in lung cancer. Cancer Gene Ther 5: 183-191. PubMed: 9622102.
-
(1998)
Cancer Gene Ther
, vol.5
, pp. 183-191
-
-
Joshi, U.S.1
Chen, Y.Q.2
Kalemkerian, G.P.3
Adil, M.R.4
Kraut, M.5
-
41
-
-
84864572894
-
Cyclin-dependent kinase inhibitor p21(Waf1): contemporary view on its role in senescence and oncogenesis
-
10.1134/S000629791206003X
-
Romanov VS, Pospelov VA, Pospelova TV, (2012) Cyclin-dependent kinase inhibitor p21(Waf1): contemporary view on its role in senescence and oncogenesis. Biochemistry (Mosc) 77: 575-584. doi:10.1134/S000629791206003X.
-
(2012)
Biochemistry (Mosc)
, vol.77
, pp. 575-584
-
-
Romanov, V.S.1
Pospelov, V.A.2
Pospelova, T.V.3
-
42
-
-
84868016543
-
EZH2: a pivotal regulator in controlling cell differentiation
-
23145205
-
Chen YH, Hung MC, Li LY, (2012) EZH2: a pivotal regulator in controlling cell differentiation. Am J Transl Res 4: 364-375. PubMed: 23145205.
-
(2012)
Am J Transl Res
, vol.4
, pp. 364-375
-
-
Chen, Y.H.1
Hung, M.C.2
Li, L.Y.3
-
43
-
-
84867397321
-
MiR-663, a microRNA targeting p21(WAF1/CIP1), promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma
-
10.1038/onc.2011.629
-
Yi C, Wang Q, Wang L, Huang Y, Li L, et al. (2012) MiR-663, a microRNA targeting p21(WAF1/CIP1), promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma. Oncogene 31: 4421-3443. doi:10.1038/onc.2011.629. PubMed: 22249270.
-
(2012)
Oncogene
, vol.31
, pp. 3443-4421
-
-
Yi, C.1
Wang, Q.2
Wang, L.3
Huang, Y.4
Li, L.5
-
44
-
-
80755144043
-
MicroRNA-423 promotes cell growth and regulates G(1)/S transition by targeting p21Cip1/Waf1 in hepatocellular carcinoma
-
10.1093/carcin/bgr199
-
Lin J, Huang S, Wu S, Ding J, Zhao Y, et al. (2011) MicroRNA-423 promotes cell growth and regulates G(1)/S transition by targeting p21Cip1/Waf1 in hepatocellular carcinoma. Carcinogenesis 32: 1641-1647. doi:10.1093/carcin/bgr199. PubMed: 21890460.
-
(2011)
Carcinogenesis
, vol.32
, pp. 1641-1647
-
-
Lin, J.1
Huang, S.2
Wu, S.3
Ding, J.4
Zhao, Y.5
|